Validation of the Quality of Life in Alzheimer's Disease (QOL-AD) scale in Mexican patients with Alzheimer, vascular and mixed-type dementia;Validación de la escala Quality of Life in Alzheimer's Disease (QOL-AD) en pacientes mexicanos con demencia tipo Alzheimer, vascular y mixta

Revista de Neurologia

Volumn 51, Issue 2, 2010, Pages 72-80

  Rosas Carrasco, Óscar ^a   Torres Arreola, Laura Del Pilar ^b   Guerra Silla, M De Guadalupe ^c   Torres Castro, Sara ^a   Gutiérrez Robledo, Luis Miguel ^a  

^a INSTITUTO NACIONAL DE GERIATRÍA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Dementia; QOL AD; Spanish; Transcultural adaptation; Validation

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CONTROLLED STUDY; GERIATRIC DEPRESSION SCALE; HUMAN; MENTAL TEST; QUALITY OF LIFE; DEMENTIA; FEMALE; MEXICO; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGY; REPRODUCIBILITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAREGIVERS; DEMENTIA; DEMENTIA, VASCULAR; FEMALE; HUMANS; MEXICO; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS;

EID: 77955755724     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5102.2009648     Document Type: Article

References (35)

1. Mejía-Arango S, Miguel-Jaimes A, Villa A, Ruiz-Arregui L, Gutiérrez-Robledo LM. Cognitive impairment and associated factors in older adults in Mexico. Salud Publica Mex 2007; 49: 475-81.
2. Connell C M, Janevic M R, Gallant M P. The costs of caring: impact of dementia on family caregivers. J Geriatr Psychiatry Neurol 2001; 14: 179-87.
3. Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, et al. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Health Technol Assess 2000; 5: 1-137.
4. Katona C, Livingston G, Cooper C, Ames D, Brodaty H, Chiu E. International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia. Int Psychogeriatr 2007; 19: 345-54.
5. Lucas-Carrasco R. Quality of life and dementia. Med Clin (Barc) 2007; 128: 70-5.
6. Baquero M, Peset V, Burguera JA, Salazar-Cifre A, Boscá-Blasco ME, Del Olmo-Rodríguez A, et al, en nombre del nodo ENAE/Valencia. Calidad de vida en la enfermedad de Alzheimer. Rev Neurol 2009; 49: 337-42.
7. Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med 2002; 64: 510-9.
8. Lawton MP. Assessing quality of life in Alzheimer disease research. Alzheimer Dis Assoc Disord 1997; 11: 91-9.
9. Matsui T, Nakaaki S, Murata Y, Sato J, Shinagawa Y, Tatsumi H, et al. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's Disease scale. Dement Geriatr Cogn Disord 2006; 21: 182-91.
10. Shin HY. A preliminary study on the Korean version of Quality of Life-Alzheimer's Disease (QOL-AD) scale in community-dwelling elderly with dementia. J Prev Med Public Health 2006; 39: 243-8.
11. Novelli MM, Dal Rovere HH, Nitrini R, Caramelli P. Cross-cultural adaptation of the quality of life assessment scale on Alzheimer disease. Arq Neuropsiquiatr 2005; 63: 201-6.
12. Thorgrimsen L, Selwood A, Spector A, Royan L, De Madariaga-López M, Woods RT, et al. Whose quality of life is it anyway? The validity and reliability of the Quality of Life-Alzheimer's Disease (QoL-AD) scale. Alzheimer Dis Assoc Disord 2003; 17: 201-8.
13. Fuh JL, Wang SJ. Assessing quality of life in Taiwanese patients with Alzheimer's disease. Int J Geriatr Psychiatry 2006; 21: 103-7.
14. Yap PLK, Goh JYN, Henderson LM, Han PM, Ong KS, Kwek SSL, et al. How do Chinese patients with dementia rate their own quality of life? Int Psychogeriatr 2008; 20: 482-93.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group Ander the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
16. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-60.
17. Chui H, Victoroff J, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473-80.
18. Guillermin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-32.
19. Mejía S, Gutiérrez-Robledo LM, Villa A, Ostrosky-Solís F. Cognition, functional status, education, and the diagnosis of dementia and mild cognitive impairment in Spanish-speaking elderly. Appl Neuropsychol 2004; 11: 194-201.
20. Baztán JJ, Pérez J, Alarcón T, San Cristóbal E, Izquierdo G, Manzarbeitia I. Índice de Barthel: instrumento válido para la valoración funcional de pacientes con enfermedad cerebrovascular. Rev Esp Geriatr Gerontol 1993; 28: 32-40.
21. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-86.
22. Boada M, Cejudo JC, Tàrraga L, López OL, Kaufer D. Neuropsychiatric Inventory Questionnaire (NPI-Q): Spanish validation of an a bridged form of the Neuropsychiatric Inventory (NPI). Neurologia 2002; 17: 317-23.
23. Sánchez-García S, Juárez-Cedillo T, García-González JJ, Espinel-Bermúdez C, Gallo JJ, Wagner FA, et al. Usefulness of two instruments in assessing depression among elderly Mexicans in population studies and for primary care. Salud Publica Mex 2008; 50: 447-56.
24. Chevalier S, Saoud F, Gray-Donald K, Morais J A. The physical functional capacity of frail elderly persons undergoing ambulatory rehabilitation is related to their nutritional status. J Nutr Health Aging 2008; 12: 721-6.
25. Flores-Castro. Validation of a Spanish version of the MNA in a Mexican population. Mininutritional Assessment (MNA). In Vellas B, ed. Research and practice in the elderly. Nestle Nutrition Workshop Series: Clinical and Performance Program. Vevey: Karger; 1999. p. 159-76.
26. Vitaliano PP, Russo J, Young HM, Becker J, Maiuro RD. The screen for caregiver burden. Gerontologist 1991; 31: 76-83.
27. Jurado S, Villegas ME, Méndez L, Rodríguez R, Loperena V, Varela, R. La estandarización del inventario de depresión de Beck para los residentes de la Ciudad de México. Salud Mental 1998; 21: 26-31.
28. Charlson M, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-83.
29. Pértegas-Díaz S, Pita-Fernández S. Determinación del tamaño muestral para calcular la significación del coeficiente de correlación lineal. CAD Aten Primaria 2001; 9: 209-11.
30. Pita-Fernández S. Determinación del tamaño muestral. CAD Aten Primaria 1996; 3: 138-43.
31. Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing changes in quality of life in Alzheimer's disease. Research and Practice in Alzheimer's Disease. France: Serdi Press; 2005.
32. MAPI Institute. URL: http://www.mapi-institute.com/ component/content/ article/6-list/125-specific-questionnairesneurology. [04.12.2009].
33. Ready RE, Ott BR, Grace J. Patient versus informant perspectives of quality of life in mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry 2004; 19: 256-65.
34. Karlawish JH, Casarett D, Klocinski J, Clark CM. The relationship between caregivers' global ratings of Alzheimer's disease patients' quality of life, disease severity, and the caregiving experience. J Am Geriatr Soc 2001; 49: 1066-70.
35. Shin IS, Carter M, Masterman D, Fairbanks L, Cummings JL. Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am J Geriatr Psychiatry 2005; 13: 469.